Pharmaceutical manufacturers, as well as other companies affected by or included in changes to pharmaceutical supply chains, are invited to join us tomorrow, April 7, for a complimentary webinar focused on current issues facing the global pharmaceutical supply chain.
- The steps that companies need to take now given the potential for international arbitration claims to arise from challenges such as export restrictions in India and decreased manufacturing of active pharmaceutical ingredients in China and elsewhere.
- Clause drafting issues.
- The consequences of choosing common law over civil law as the governing law of the contract.
- How to select arbitrators for pharmaceutical supply chain disputes.
- How companies should address indemnification obligations and insurance matters.
To register for the webinar, please click here.
This program is presumptively approved for 1.0 general CLE credit in California, Illinois, New Jersey, Pennsylvania, Texas and West Virginia. For lawyers licensed in New York, this course is eligible for 1.0 credit under New York’s Approved Jurisdiction Policy. Please allow four weeks after the program to receive a certificate of attendance.